Searched for
CDSCO PANEL
Why CDSCO and BEE have not kept pace with the industries they overseeCDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...- Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concernsA Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...
- Ease of reading medicine labels, for everyoneCentral Drugs Standard Control Organisation or CDSCO plans Braille labels and QR codes on medicine packs. This will help visually impaired ...
- Chemists selling spurious meds may face prosecutionThe government has established a committee to create rules for prosecuting chemists and retailers selling spurious drugs. This initiative a...
- Govt panel to review if nutraceuticals should be brought under CDSCONutraceuticals are products derived from food sources that are believed to provide extra health benefits besides the basic nutritional valu...
- Govt forms panel to study WHO report on deaths of 66 Gambian children linked to 4 Indian syrupsThe development comes on a day the Haryana government ordered the halting of drug manufacturing at the Sonipat unit of Maiden Pharmaceutica...
- Awaiting regulatory approvals to launch Covaxin for children: Bharat Biotech"This represents one of the first approvals worldwide for COVID-19 vaccines for the 2-18 age group. Bharat Biotech sincerely thanks the DCG...
- Top experts finds no proof baricitinib works against CovidExperts are of the view that the clinicians can use it in their wisdom, but decided against recommending the drug in the national guideline...
- Bharat Biotech's Covaxin recommended by expert panel for phase 2/3 trials on 2-18 year-oldsThe Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organization deliberated upon Hyderabad-based Bharat Biotech...
- SEC recommends Bharat Biotech’s Covaxin for emergency useThe Drug Controller General of India (DCGI) will give the final approval to both the vaccine candidates.
- India can expect a Happy New Year with Covid vaccines in hand: CDSCO, DGSomani’s statement on Thursday comes on the day Prime Minister Narendra Modi said India is making preparations for the largest adult immuni...
- Dr Reddy's Laboratories to submit a revised protocol for conducting clinical trials of Russian COVID-19 vaccineIn a meeting held on Monday, Subject Expert Committee (SEC) on COVID-19 at the CDSCO, deliberated on the application and asked the firm to ...
- High-level government panel suggests single-window system for new drug approvalsThe committee, set up by the cabinet secretary after Prime Minister Narendra Modi sought overhauling of the country’s drug regulatory syste...
- Panel recommends renaming India's drug regulator for better international visibilityA high-level committee has proposed three options — Central Medical Products Administration, India (CMPA), Central Medical Products Regulat...
- Faster nod for clinical trials of all drugs and vaccines soonA committee led by cabinet secretary Rajiv Gauba has also decided to set up a nodal coordination committee to ensure expeditious disposal o...
- High-level panel formed to recommend reforms in India's drug regulatory systemFaced with the ominous threat of the coronavirus infection, a number of steps such as fast-tracking the approval process for drugs, researc...
- J&J case: Government asks 'victims' to approach central or state panelIf the affected patients approach the state-level committee, they may write to the concerned state drug controller who will be the member s...
- Johnson & Johnson case: Parliament panel members lash out at CDSCODrug regulator accused of "criminal negligence" for taking 3 years to issue a medical device alert about the faulty implants.
- Interim relief: J&J told to pay Rs 20 lakh to each recipient of faulty hip implantAll patients who got the implants will be evaluated individually to gauge the extent of medical problems arising from the bad implants and ...
- Act against erring doctors: House Panel tells Health MinistryThe panel took note of specific cases, where approvals were granted for additional use for existing drugs without mandatory clinical trials.
Load More
